These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3087628)

  • 1. Tandem kappa immunoglobulin promoters are equally active in the presence of the kappa enhancer: implications for models of enhancer function.
    Atchison ML; Perry RP
    Cell; 1986 Jul; 46(2):253-62. PubMed ID: 3087628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunoglobulin promoter displays cell-type specificity independently of the enhancer.
    Foster J; Stafford J; Queen C
    Nature; 1985 May 30-Jun 5; 315(6018):423-5. PubMed ID: 3923370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between immunoglobulin enhancers and promoters.
    Garcia JV; Bich-Thuy LT; Stafford J; Queen C
    Nature; 1986 Jul 24-30; 322(6077):383-5. PubMed ID: 3016550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endogenous immunoglobulin heavy chain enhancer can activate tandem VH promoters separated by a large distance.
    Wang XF; Calame K
    Cell; 1985 Dec; 43(3 Pt 2):659-65. PubMed ID: 2866846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
    Liu Z; Garrard WT
    Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 3' Igkappa enhancer contains RNA polymerase II promoters: implications for endogenous and transgenic kappa gene expression.
    Shen HM; Peters A; Kao D; Storb U
    Int Immunol; 2001 May; 13(5):665-74. PubMed ID: 11312254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type specific regulation of a kappa immunoglobulin gene by promoter and enhancer elements.
    Queen C; Foster J; Stauber C; Stafford J
    Immunol Rev; 1986 Feb; 89():49-68. PubMed ID: 3081432
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers.
    Parslow TG; Jones SD; Bond B; Yamamoto KR
    Science; 1987 Mar; 235(4795):1498-501. PubMed ID: 3029871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.
    Fulton R; Van Ness B
    Nucleic Acids Res; 1993 Oct; 21(21):4941-7. PubMed ID: 8177743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated.
    Kelley DE; Pollok BA; Atchison ML; Perry RP
    Mol Cell Biol; 1988 Feb; 8(2):930-7. PubMed ID: 3127693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription.
    Atchison ML; Perry RP
    Cell; 1987 Jan; 48(1):121-8. PubMed ID: 3098435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences.
    Sen R; Baltimore D
    Mol Cell Biol; 1987 May; 7(5):1989-94. PubMed ID: 3110599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of antibody cDNA in murine myeloma cells: possible involvement of additional regulatory elements in transcription of immunoglobulin genes.
    Weidle UH; Koch S; Buckel P
    Gene; 1987; 60(2-3):205-16. PubMed ID: 3127273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two regulatory elements for immunoglobulin kappa light chain gene expression.
    Bergman Y; Rice D; Grosschedl R; Baltimore D
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7041-5. PubMed ID: 6438631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early B cell factor interacts with a subset of kappa promoters.
    Sigvardsson M; Akerblad P; Leanderson T
    J Immunol; 1996 May; 156(10):3788-96. PubMed ID: 8621915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.
    Cockerill PN; Garrard WT
    Cell; 1986 Jan; 44(2):273-82. PubMed ID: 3002631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
    Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
    Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site.
    Pelletier MR; Hatada EN; Scholz G; Scheidereit C
    Nucleic Acids Res; 1997 Oct; 25(20):3995-4003. PubMed ID: 9321649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
    Singh H; Sen R; Baltimore D; Sharp PA
    Nature; 1986 Jan 9-15; 319(6049):154-8. PubMed ID: 3079885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.